Safety and Efficacy of NDTx-03 in Children and Adolescents With ASD or SCD
NCT: NCT07770867 · RECRUITING
広告
NCT識別子NCT07770867
ステータスRECRUITING
開始日2026-09-15
SponsorNeudive Inc. (INDUSTRY)
First posted
Last updated
概要
The purpose of this study is to evaluate the safety of NDTx-03 used together with treatment as usual (TAU) and to determine whether NDTx-03 plus TAU is more effective than TAU alone in improving social situation recognition and interaction in children and adolescents with autism spectrum disorder (ASD) or social communication disorder (SCD).
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。